The therapy, called AMT-130 and developed by UniQure, is delivered directly into the deep structures of the brain most ...

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...

Huntington’s is caused by a single error in our DNA, a “typo” in a gene responsible for creating a protein called huntingtin.

For the first time, doctors have successfully slowed the progression of Huntington's disease by 75%, offering hope to patients and their families. Huntington’s disease, a cruel genetic disorder that ...

A woman who has claimed she is living with a 'death sentence' has explained her condition, and why it has come back to bite her 50 years after. Back in 1975, Natalie Bralee-Brett was three and ...

After 18 months of community donations and pledges, totalling over $8 million, the Palmerston and District Hospital finally has a new MRI machine and suite.  The hospital officially opened the new ...

MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI ...

In an update from uniQure, they report that their experimental gene therapy, AMT-130, has the potential to slow Huntington’s ...

Scientists have achieved first-ever successful treatment for one of the most devastating genetic diseases, Huntington’s in a recent medical breakthrough. In the pivotal research study, ...

Medical researchers have announced a revolutionary breakthrough in treating Huntington's disease, achieving a remarkable 75 ...

Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared to a propensity score-matched external cont ...